During the past decade, Newport Native MD, Inc conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Newport Native MD, Inc" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Baxalta now part of Shire" with 1 trials sponsored, "Exact Sciences Corporation" with 1 trials sponsored, "Insmed Incorporated" with 1 trials sponsored and "Organicell Regenerative Medicine" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Newport Native MD, Inc" #1 collaborator was "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator and "HealthCore-NERI" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Newport Native MD, Inc" are "Alpha1-antitrypsin Deficiency" (1 trials), "Bronchiectasis" (1 trials), "COVID-19" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Healthy" (1 trials). Many other conditions were trialed in "Newport Native MD, Inc" in a lesser frequency.

Most popular intervention types in "Newport Native MD, Inc" are "Drug" (5 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "ARALAST NP 120 mg/kg" (1 trials), "ARALAST NP 60 mg/kg" (1 trials), "BI 1291583" (1 trials) and "Blood Sample Collection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Newport Native MD, Inc" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Newport Native MD, Inc". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Newport Native MD, Inc, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Newport Native MD, Inc, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".